⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 2, 2024Open Access

Supplementary figure 8 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer

Maddison Archer Diane Begemann Edgar Gonzalez‐Kozlova Prerna R. Nepali Estefanía Labanca Peter D.A. Shepherd Navneet Dogra Nora M. Navone Natasha Kyprianou

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

SLCO1B3 expression in PDX from lethal prostate cancer

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Archer et al. (2024) studied this question.

synapsesocial.com/papers/68e5daeeb6db643587570f35 https://doi.org/10.1158/1541-7786.26467189.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary figure 8 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024
2Supplementary figure 10 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024
3Supplementary figure 10 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024
4Supplementary figure 16 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024
5Supplementary figure 16 from Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer2024